Evidence map›Paper›PMID 29440485›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents.

Masahito Yamagata, Joshua R Sanes

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Production of high-affinity glycosylated anti-mouse conjugated nanobodies inFrontiers in bioengineering and biotechnology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Chimeric Protein Switch Biosensors.Advances in biochemical engineering/biotechnology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Construction of Synthetic VHH Libraries in Ribosome Display Format.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masahito YamagataCenter for Brain Science, Harvard University, Cambridge MA, 02138.ORCID 0000-0001-8193-2931
Joshua R SanesCenter for Brain Science, Harvard University, Cambridge MA, 02138; sanesj@mcb.harvard.edu.ORCID 0000-0001-8926-8836

Funding

Synaptic Choices in the Retinotectal SystemR37NS029169 · NINDS · HARVARD UNIVERSITY · PI SANES, JOSHUA R · 2013 to 2019
$4.0M
NINDS NIH HHS R37 NS029169
6 · The paper itself

Abstract

Sensitive and specific antibodies are essential for detecting molecules in cells and tissues. However, currently used polyclonal and monoclonal antibodies are often less specific than desired, difficult to produce, and available in limited quantities. A promising recent approach to circumvent these limitations is to employ chemically defined antigen-combining domains called "nanobodies," derived from single-chain camelid antibodies. Here, we used nanobodies to prepare sensitive unimolecular detection reagents by genetically fusing cDNAs encoding nanobodies to enzymatic or antigenic reporters. We call these fusions between a reporter and a nanobody "RANbodies." They can be used to localize epitopes and to amplify signals from fluorescent proteins. They can be generated and purified simply and in unlimited amounts and can be preserved safely and inexpensively in the form of DNA or digital sequence.

Indexed as

Amino Acid SequenceAnimalsAntibody SpecificityAntigen-Antibody ReactionsCamelusDNA, ComplementaryEnzyme-Linked Immunosorbent AssayGreen Fluorescent ProteinsImmunohistochemistrySensitivity and SpecificitySingle-Domain AntibodiesDNA, ComplementaryGreen Fluorescent ProteinsSingle-Domain Antibodiescamelid antibodyGFPhorseradish peroxidasenanobodyretina

Identifiers

PMID29440485
PMCPMC5834735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.